NRx Pharmaceuticals, Inc.
NRXPNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $102.03M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.62$5.06
- Volume (live)
- -
- Avg. volume (3M)
- 684.66K
NRx Pharmaceuticals (NRXP) Stock Price & Financial Analysis
NRx Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.57 - $2.76 |
|---|---|
| 52-Week High | $5.06 |
| 52-Week Low | $1.62 |
| Open | $2.70 |
| Volume (last close) | 1.21M |
| Average Volume (3M) | 684.66K |
| Revenue (TTM) | 3.39M |
|---|---|
| Net Income (TTM) | -23.48M |
| Free Cash Flow (TTM) | -20.67M |
| EPS (TTM) | −$0.76 |
| Profit Margin | -691.81% |
| Operating Margin | -585.47% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 102.03M |
|---|---|
| Shares Outstanding | 37.65M |
| Price to Sales (P/S) | 30.06 |
| Price to Book (P/B) | -600.18 |
| EV/EBITDA | -3.49 |
| 50-Day MA | $3.24 |
|---|---|
| 200-Day MA | $2.96 |
| 1-Year Change | −14.78% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
NRx Pharmaceuticals at a Glance
As of the Oct 16, 2026 close, NRx Pharmaceuticals (NRXP) has a market capitalization of $102.03M. The stock trades at 30.1× sales. Over the trailing twelve months it lost $23.48M on revenue of $3.39M and burned $20.67M of free cash flow. Revenue grew 1302.5% year over year.
As of its latest reported balance sheet, it holds $26.69M in cash and securities against $1.25M of debt, a net cash position of $25.44M.
NRx Pharmaceuticals does not currently pay a dividend.
The share price is down 14.8% over the past year. At $2.60 (the Oct 16, 2026 close) it sits within its 52-week range of $1.62 to $5.05, below its 200-day moving average of $2.96.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $35.00, 1246.2% above the Oct 16, 2026 close.
Frequently Asked Questions About NRx Pharmaceuticals
What is the current stock price for NRXP?
As of the Oct 16, 2026 close, NRXP stock trades at $2.60. The 52-week range is $1.62–$5.06, with a day range of $2.57–$2.76.
What is the P/E ratio for NRXP?
The P/E ratio (Price-to-Earnings) for NRXP is shown in the Key Statistics section. This valuation metric helps compare NRx Pharmaceuticals, Inc. to industry peers.
Does NRXP pay dividends?
NRx Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for NRXP?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for NRXP is Buy. The average 12-month price target is $35.00, a 1246.2% upside from the Oct 16, 2026 close of $2.60.
What is the market cap of NRXP?
As of the Oct 16, 2026 close, NRx Pharmaceuticals's market capitalization is $97.9M, classifying it as a micro-cap company. NRx Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.